SCHEMBL3707932

SCHEMBL3707932

CC(=O)C1=C(O)C(=O)N(CCCc2ccccc2)C1c1ccc(Br)cc1.CC(=O)C1=C(O)C(=O)N(CCc2cccc3ccccc23)C1c1ccc(Br)cc1

nearest known ligand 0.59

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.59
KMT2A Q03164 3/20 0.59
ALDH1A1 P00352 5/20 0.53
KDM4E B2RXH2 2/20 0.53
MAPT P10636 2/20 0.53
HTT P42858 2/20 0.53
USP7 Q93009 1/20 0.53
RXFP1 Q9HBX9 1/20 0.53
TP53 P04637 1/20 0.53
MDM2 Q00987 1/20 0.53
HPGD P15428 1/20 0.53
ALOX15 P16050 3/20 0.47
TSHR P16473 2/20 0.47
FPR1 P21462 1/20 0.47
HIF1A Q16665 1/20 0.47
LMNA P02545 1/20 0.46
POLB P06746 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3710669 0.92 MEN1 (0.59) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL3709204 0.88 MEN1 (0.74) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL3715641 0.85 MEN1 (0.73) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL3705340 0.84 MEN1 (0.78) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL6781299 0.82 MEN1 (0.68) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL3704381 0.80 MEN1 (0.70) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL3705385 0.79 USP7 (0.79) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL3714403 0.78 USP7 (0.69) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL3708650 0.78 USP7 (0.69) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL3706264 0.78 MEN1 (0.60) MEN1KMT2AALDH1A1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010081783-A1 NOVEL SPECIFIC INHIBITORS OF UBIQUITIN SPECIFIC PROTEASE 7, THE PHARMACEUTICAL COMPOSITIONS THEREOF AND THEIR THERAPEUTIC APPLICATIONS HYBRIGENICS SA (FR) 2010-07-22 WO claimed